Tyme Technologies, Inc.
(NASDAQ : TYME)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc.
0.12%69.252.3%$1202.98m
PFEPfizer Inc.
0.32%42.990.9%$972.86m
JNJJohnson & Johnson
-0.42%131.940.7%$941.91m
MRKMerck & Co., Inc.
0.17%81.730.6%$784.11m
BMYBristol-Myers Squibb Company
-0.63%44.171.4%$644.43m
LLYEli Lilly and Company
-0.46%108.321.0%$344.62m
NVSNovartis AG Sponsored ADR
1.57%90.560.2%$146.46m
GSKGlaxoSmithKline plc Sponsored ADR
-0.09%41.150.2%$93.85m
AZNAstraZeneca PLC Sponsored ADR
0.60%40.441.2%$89.77m
SNYSanofi Sponsored ADR
-0.38%41.670.2%$70.58m
NVONovo Nordisk A/S Sponsored ADR Class B
1.13%48.260.1%$67.12m
LCILannett Company, Inc.
-2.93%5.6036.6%$4.06m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.60%1.861.6%$0.27m
EPIXESSA Pharma Inc
-3.01%2.900.1%$0.01m

Company Profile

Tyme Technologies, Inc. is a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in New York, NY.